Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 665

[184] Nishihata T, Okamura Y, Kamada A, Higuchi T, Yagi T, Kawamori R, et al. Enhanced
bioavailability of insulin after rectal administration with enamine as adjuvant in depan-
creatized dogs. J Pharm Pharmacol 1985;37:22-6.
[185] Hosny EA, Al-Shora HI, Elmazar MM. Relative hypoglycemic effect of insulin sup-
positories in diabetic beagle dogs: optimization of various concentrations of sodium
salicylate and polyoxyethylene-9-lauryl ether. Biol Pharm Bull 2001;24:1294-7.
[186] Ichikawa K, Ohata I, Mitomi M, Kawamura S, Maeno H, Kawata H. Rectal absorption
of insulin suppositories in rabbits. J Pharm Pharmacol 1980;32:314-18.
[187] Kosior A. Investigation of physical and hypoglycaemic properties of rectal supposito-
ries with chosen insulin. Acta Pol Pharm 2002;59:353-8.
[188] Nakanishi K, Ogata A, Masada M, Nadai T. Effect of nonsteroidal anti-inflammatory
drugs on the permeability of the rectal mucosa. Chem Pharm Bull 1984;32:1956-66.
[189] Nakanishi K, Masada M, Nadai T. Effect of nonsteroidal anti-inflammatory drugs on the
absorption of macromolecular drugs in rat rectum. Chem Pharm Bull 1986;34:2628-31.
[190] Mizuno A, Ueda M, Kawanishi G. Effects of salicylate and other enhancers on rectal
absorption of erythropoietin in rats. J Pharm Pharmacol 1992;44:570-3.
[191] Nishihata T, Rytting JH, Higuchi T, Caldwell L. Enhanced rectal absorption of insu-
lin and heparin in rats in the presence of non-surfactant adjuvants. J Pharm Pharmacol
1981;33:334-5.
[192] West GB. Rectal absorption of dextran in rats in the presence of salicylates. Int Arch
Allergy Immunol 1982;68:283-5.
[193] Hosny E, el-Ahmady O, el-Shattawy H, Nabih Ael-M, el-Damacy H, Gamal-
el-Deen S, et al. Effect of sodium salicylate on insulin rectal absorption in humans.
Arzneimittelforschung Beih. 1994;44:611-13.
[194] Hauss DJ, Ando HY. The influence of concentration of two salicylate derivatives on
rectal insulin absorption enhancement. J Pharm Pharmacol 1988;40:659-61.
[195] Watanabe Y, Kiriyama M, Ito R, Kikuchi R, Mizufune Y, Nomura H, et al.
Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-
stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle. Biol Pharm
Bull 1996;19:1059-63.
[196] Nakanishi K, Masada M, Nadai T. Effect of pharmaceutical adjuvants on the rectal per-
meability of drugs. II. Effect of Tween-type surfactants on the permeability of drugs in
the rat rectum. Chem Pharm Bull 1983;31:3255-63.
[197] Kunio N, Shozo M, Mikio M, Tanekazu N. Effect of pharmaceutical adjuvants on the
rectal permeability of drugs. Effect of pharmaceutical additives on the permeability of
sulfaguanidine through the rat rectum. Yakugaku Zasshi 1982;102:1133-40.
[198] Muranishi S. Modification of intestinal absorption of drugs by lipoidal adjuvants. Pharm
Res 1985;2:108-18.
[199] Akira K, Masahiro H, Toshiharu H, Shoji A, Haruo M, Manabu H. Solvent drag
effect in drug intestinal absorption. I. Studies on drug and D 2 O absorption clearances.
J Pharmacobio-Dyn 1982;5:410-17.
[200] Nishihata T, Rytting JH. Absorption-promoting adjuvants: enhancing action on rectal
absorption. Adv Drug Deliv Rev 1997;28:205-28.
[201] Kajii H, Horie T, Hayashi M, Awazu S. Fluorescence study on the interaction of sali-
cylate with rat small intestinal epithelial cells: possible mechanism for the promoting
effects of salicylate on drug absorption in vivo . Life Sci 1985;37:523-30.
[202] Kajii H, Horie T, Hayashi M, Awazu S. Effects of salicylic acid on the permeability of the
plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach
to elucidate the mechanism of promoted drug absorption. J Pharm Sci 1986;75:475-578.